Harrow Health, Inc.

NASDAQ:HROW

Drug Manufacturers - Specialty & Generic

Healthcare
$32.16 +0.29%

+$0.12 today

Market cap
$1.21B
Beta
0.28
P/E (TTM)
-104.7
EPS (TTM)
-$0.40
52W Low $28.54High $54.85

Volume 0.87M

Average 0.75M

HROW Short-term Debt

Borrowings and the current portion of long-term debt due within one year.

Harrow Health, Inc.NASDAQ: HROW

Short-term Debt · Q1 FY2026 · quarter ended Mar 2026

Short-term debt falls 99.2% from a year ago

Short-term debt stood at $915K at the end of Q1 FY2026, down 99.2% from a year earlier.

Context

  • Short-term debt amounted to 0.2% of total assets at the end of Q1 FY2026, down 29.5 pp from a year earlier.
  • Short-term debt increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether short-term debt keeps falling in the next quarterly balance sheet after a -99.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$915K— QoQ
Last fiscal yearDec 2025
$887K— YoY
Year agoMar 2025
$108.31M-99.2% since
Short-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-99.2%——
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Debt history

USD · from the balance sheet

Latest · FY2025
887K USD
Year-over-year change
—

Short-term Debt vs competitors

How HROW compares with its peers on the latest reported figures

  • Peers report in different currencies, so short-term debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -99.2% is the 3rd highest of 4, against a peer median of +32.0%.
  • Short-term debt amounts to 0.2% of total assets for HROW, versus a peer median of 0.2%.
HROW Competitors
Short-term Debt for HROW and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BLCOBausch + Lomb CorporationJun 2026$43M USD+53.6%+14.7%0.3%
OTLKOutlook Therapeutics, Inc.Mar 2026$15.85M USD+32.0%+40.0%72.4%
OCULOcular Therapeutix, Inc.Mar 2026$3.17M USD——0.4%
HROWHarrow Health, Inc.Mar 2026$915K USD-99.2%—0.2%
OCSOculis Holding AGMar 2026CHF 414.76K CHF——0.2%
TTRXTurn Therapeutics Inc.Mar 2026$47.8K USD——0.3%
KODKodiak Sciences Inc.Sep 2026$0 USD—+6.7%0.0%
TARSTarsus Pharmaceuticals, Inc.Sep 2026$0 USD-100.0%—0.0%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$0 USD——0.0%
Peer median (excluding HROW) —+32.0%+14.7%0.2%

Competitors are the stored peer set for HROW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents42.17M96.27M74.09M47.25M72.93M
Short-term Investments8.5M5.59M8.68M00
Net Receivables4.52M6.39M36.49M116.6M110.9M
Inventory4.22M6.54M10.87M10.7M13.52M
Other Current Assets92K118K1.75M3.41M2.13M
Total Current Assets60.66M118.26M139.07M189.65M211.75M
Property, Plant & Equipment (Net)9.08M11M12.44M12.29M11.04M
Goodwill332K332K332K332K332K
Intangible Assets17.13M25.84M159.91M186.7M175.17M
Long-term Investments11.13M0000
Tax Assets(12.45M)0000
Other Non-current Assets12.45M1.95M001.18M
Total Non-current Assets37.67M39.12M172.68M199.32M187.73M
Total Assets98.33M157.38M311.76M388.97M399.48M
Account Payables5.17M6.44M21.42M38.76M35.36M
Short-term Debt00806K0887K
Tax Payables00000
Deferred Revenue16K113K044K788K
Other Current Liabilities1.16M021.66M059.27M
Total Current Liabilities9.72M18.63M49.34M91.34M96.3M
Long-term Debt71.65M104.17M183.17M219.54M243.18M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities002.71M00
Total Non-current Liabilities77.68M111.51M192.41M228.33M251.09M
Total Liabilities87.4M130.14M241.75M319.67M347.39M
Common Stock27K30K35K35K37K
Retained Earnings(95.41M)(109.49M)(133.9M)(151.39M)(156.52M)
Accumulated OCI00(409K)00
Other Stockholders Equity00000
Minority Interest(355K)(355K)(355K)(355K)(355K)
Total Equity10.93M27.24M70M69.3M52.09M
Total Debt77.96M112.23M190.5M228.83M251.98M
Net Debt35.79M15.96M116.42M181.58M179.05M

Harrow Health, Inc.

NASDAQ:HROW

Intrinsic Alpha fair value

Locked

Current Price

$32.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.